Leerink downgrades InflaRx to Market Perform from Outperform, PT $2.

Wednesday, Dec 3, 2025 8:48 am ET1min read
IFRX--

Leerink downgrades InflaRx to Market Perform from Outperform, PT $2.

Leerink downgrades InflaRx to Market Perform from Outperform, PT $2.

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet